| Development of a New HIV Vaccine (NCT00051922) | National Institute of Allergy and Infectious Diseases (NIAID) | 1997-10-01 |
| A Study to Evaluate the Effects of Giving Interleukin-2 (IL-2) Plus Anti-HIV Therapy to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3 (NCT00000889) | National Institute of Allergy and Infectious Diseases (NIAID) | 1997-10-01 |
| Safety, Tolerability, and Anti-HIV Activity of DMP 266 (Efavirenz) in Combination With Nelfinavir in HIV-Positive Children (NCT00000893) | National Institute of Allergy and Infectious Diseases (NIAID) | 1997-10-01 |
| Long-Term Assessment for Metabolic, Cardiovascular and Neurologic Problems in HIV-Infected Patients With Increased CD4 Cells Counts Following Anti-HIV Therapy (NCT00000883) | National Institute of Allergy and Infectious Diseases (NIAID) | 1997-10-01 |
| Use of Bromodeoxyuridine to Study White Blood Cell Replication and Survival in HIV-Infected Patients (NCT00001650) | National Institute of Allergy and Infectious Diseases (NIAID) | 1997-09-19 |
| Interleukin 12 (IL-12) for the Treatment of Cryptosporidiosis in AIDS Patients (NCT00057486) | National Institute of Allergy and Infectious Diseases (NIAID) | 1997-09-01 |
| Setting up a Blood Bank for Gene Therapy in HIV-Infected Infants (NCT00000917) | National Institute of Allergy and Infectious Diseases (NIAID) | 1997-09-01 |
| Structure of the Herpes Simplex Virus Receptor (NCT00001648) | National Institute of Allergy and Infectious Diseases (NIAID) | 1997-08-20 |
| Valaciclovir to Prevent Transmission of Herpes Simplex Virus (NCT00001649) | National Institute of Allergy and Infectious Diseases (NIAID) | 1997-08-01 |
| White Blood Cell Infusions to Treat HIV Infection (NCT00001647) | National Institute of Allergy and Infectious Diseases (NIAID) | 1997-08-01 |
| A Pilot Study of the Short-Term Effects of Antiretroviral Management Based on Plasma Genotypic Antiretroviral Resistance Testing (GART) Compared With Antiretroviral Management Without Plasma GART (NCT00000874) | National Institute of Allergy and Infectious Diseases (NIAID) | 1997-08-01 |
| Voriconazole vs. Amphotericin B in the Treatment of Invasive Aspergillosis (NCT00001646) | National Institute of Allergy and Infectious Diseases (NIAID) | 1997-08-01 |
| A Phase I Safety and Immunogenicity Trial of the Facilitated HIV-1 Gag-Pol DNA Vaccine (APL-400-047, Apollon, Inc.) Given Intramuscularly by Needle and Syringe or Biojector 2000 Needle-Free Jet Injection System in HIV-1 Uninfected Adult Volunteers (NCT00001088) | National Institute of Allergy and Infectious Diseases (NIAID) | 1997-07-01 |
| Activation and Function of Eosinophils in Conditions With Blood or Tissue Eosinophilia (NCT00001406) | National Institute of Allergy and Infectious Diseases (NIAID) | 1997-04-21 |
| Use of Combined Antiretroviral Therapy to Determine Sites of Persistent HIV Infection (NCT00001644) | National Institute of Allergy and Infectious Diseases (NIAID) | 1997-03-03 |
| A Study to Evaluate the Use of Memantine In Combination With Anti-HIV Drugs to Treat AIDS Dementia Complex (ADC) (NCT00000867) | National Institute of Allergy and Infectious Diseases (NIAID) | 1996-12-01 |
| The Safety and Effectiveness of Adefovir Dipivoxil in the Treatment of HIV-Infected Patients (NCT00001082) | National Institute of Allergy and Infectious Diseases (NIAID) | 1996-12-01 |
| Evaluation and Long-Term Follow-Up of Patients With Allergic and Inflammatory Disorders (NCT00557895) | National Institute of Allergy and Infectious Diseases (NIAID) | 1996-08-26 |
| Phase II Study of Fluconazole for Lymphocutaneous and Visceral Sporotrichosis (NCT00004938) | National Institute of Allergy and Infectious Diseases (NIAID) | 1996-08-01 |
| The Effects of Prednisone on HIV Levels and the Immune System (NCT00000921) | National Institute of Allergy and Infectious Diseases (NIAID) | 1996-08-01 |
| Fluconazole Prophylaxis of Thrush in AIDS (NCT00001542) | National Institute of Allergy and Infectious Diseases (NIAID) | 1996-07-01 |
| A Comprehensive Clinical, Microbiological and Immunological Assessment of Patients With Suspected Post Treatment Lyme Disease Syndrome and Selected Control Populations (NCT00001539) | National Institute of Allergy and Infectious Diseases (NIAID) | 1996-06-13 |
| A Comparison of Two Caloric Supplements in the Prevention of Weight Loss in Patients With AIDS Who Take Daily Multivitamin and Mineral Supplements (NCT00001077) | National Institute of Allergy and Infectious Diseases (NIAID) | 1996-06-01 |
| Genetic Studies of X-linked Lymphoproliferative Disease (NCT00359411) | National Institute of Allergy and Infectious Diseases (NIAID) | 1996-05-22 |
| The Use of Bacteriophage Phi X174 to Assess the Immune Competence of HIV-Infected Patients In Vivo (NCT00001540) | National Institute of Allergy and Infectious Diseases (NIAID) | 1996-04-01 |
| Analysis of Bronchial Tissue and Fluid in Patients With Wegener's Granulomatosis (NCT00001541) | National Institute of Allergy and Infectious Diseases (NIAID) | 1996-04-01 |
| Phase I Study of APL 400-003, a Candidate HIV Vaccine, in HIV-Negative Volunteers (NCT00001538) | National Institute of Allergy and Infectious Diseases (NIAID) | 1996-03-01 |
| Resistance to HIV Infection (NCT00069485) | National Institute of Allergy and Infectious Diseases (NIAID) | 1995-12-01 |
| Allopurinol, Glucantime, or Allopurinol/Glucantime for Cutaneous Leishmaniasis in Brazil (NCT00004755) | National Institute of Allergy and Infectious Diseases (NIAID) | 1995-09-01 |
| Monitoring Patients for Developing Communicable and Opportunistic Infections and for Responding to Therapy (NCT00001477) | National Institute of Allergy and Infectious Diseases (NIAID) | 1995-08-01 |
| Genetic Analysis of Immune Disorders (NCT00001467) | National Institute of Allergy and Infectious Diseases (NIAID) | 1995-06-06 |
| Gene Therapy for Chronic Granulomatous Diseases - Long-term Follow-up (NCT00001476) | National Institute of Allergy and Infectious Diseases (NIAID) | 1995-06-01 |
| Home Treatment of HIV-Infected Patients With Interleukin-2 With or Without a Tumor Necrosis Factor Antagonist (NCT00001475) | National Institute of Allergy and Infectious Diseases (NIAID) | 1995-06-01 |
| Pharmacodynamics of Intermittent IL-2 Infusions in HIV Seropositive Patients (NCT00001474) | National Institute of Allergy and Infectious Diseases (NIAID) | 1995-05-01 |
| Cyclophosphamide and Prednisone Followed by Methotrexate To Treat Vasculitides (NCT00001473) | National Institute of Allergy and Infectious Diseases (NIAID) | 1995-03-01 |
| Evaluation and Monitoring of Patients With HIV Infectionn (NCT00557570) | National Institute of Allergy and Infectious Diseases (NIAID) | 1995-02-11 |
| Tissue Biopsy and Imaging Studies in HIV-Infected Patients (NCT00001471) | National Institute of Allergy and Infectious Diseases (NIAID) | 1994-11-30 |
| The Efficacy of a Standardized Acupuncture Regimen and Amitriptyline Compared With Placebo as a Treatment for Pain Caused by Peripheral Neuropathy in HIV-Infected Patients (NCT00000817) | National Institute of Allergy and Infectious Diseases (NIAID) | 1994-11-01 |
| Women's Interagency HIV Study (WIHS) (NCT00000797) | National Institute of Allergy and Infectious Diseases (NIAID) | 1994-10-01 |
| A Study of Psychosocial and Behavioral Determinants of Differential Rates of Participant Compliance in CPCRA Protocols (NCT00000784) | National Institute of Allergy and Infectious Diseases (NIAID) | 1994-10-01 |
| Role of T-Cells in Asthma (NCT00001408) | National Institute of Allergy and Infectious Diseases (NIAID) | 1994-09-14 |
| Genetically Modified Lymphocytes to Treat HIV-Infected Identical Twins - Study Modifications (NCT00001409) | National Institute of Allergy and Infectious Diseases (NIAID) | 1994-09-01 |
| Heterosexual HIV Transmission Study (HATS) (NCT00000783) | National Institute of Allergy and Infectious Diseases (NIAID) | 1994-06-01 |
| Interferon Gamma for Drug Resistant Tuberculosis (NCT00001407) | National Institute of Allergy and Infectious Diseases (NIAID) | 1994-05-01 |
| Host Response to Infection and Treatment in Lymphatic Filarial Disease in India (NCT00342576) | National Institute of Allergy and Infectious Diseases (NIAID) | 1994-04-23 |
| Recruitment and Apheresis Collection of Peripheral Blood Hematopoietic Stem Cells, Mononuclear Cells and Granulocytes (NCT00001405) | National Institute of Allergy and Infectious Diseases (NIAID) | 1994-02-27 |
| Detection and Characterization of Host Defense Defects (NCT00001355) | National Institute of Allergy and Infectious Diseases (NIAID) | 1993-09-01 |
| Subcutaneously Administered Interleukin-2 Therapy in HIV-Infected Patients (NCT00001357) | National Institute of Allergy and Infectious Diseases (NIAID) | 1993-08-01 |
| Evaluation and Long-Term Follow-up of Patients With Inflammatory Disorders (NCT00001351) | National Institute of Allergy and Infectious Diseases (NIAID) | 1993-06-01 |
| Study of Autoimmune Lymphoproliferative Syndrome (ALPS) (NCT00001350) | National Institute of Allergy and Infectious Diseases (NIAID) | 1993-05-13 |
| Characteristics of Mast Cells in Mastocytosis (NCT00001356) | National Institute of Allergy and Infectious Diseases (NIAID) | 1993-05-01 |
| Fungal Infection Susceptibility (NCT00001352) | National Institute of Allergy and Infectious Diseases (NIAID) | 1993-04-01 |
| Apheresis to Obtain Plasma or White Blood Cells for Laboratory Studies (NCT00001349) | National Institute of Allergy and Infectious Diseases (NIAID) | 1993-03-23 |
| Studies of the Pathogenesis of HIV Infection in Human Peripheral Blood Cells and/or Body Fluids in People Living With and Without HIV (NCT00001281) | National Institute of Allergy and Infectious Diseases (NIAID) | 1993-03-09 |
| Interleukin-2 Therapy for HIV Infection - Supplemental Procedures (NCT00001354) | National Institute of Allergy and Infectious Diseases (NIAID) | 1993-03-01 |
| Safety and Survival of Genetically Modified White Blood Cells in HIV-Infected Persons - A Study in Identical Twin Pairs (NCT00001353) | National Institute of Allergy and Infectious Diseases (NIAID) | 1993-03-01 |
| Phase III Randomized, Double-Blind, Placebo-Controlled Study of Acellular and Whole-Cell Pertussis Vaccines (NCT00004800) | National Institute of Allergy and Infectious Diseases (NIAID) | 1992-09-01 |
| Evaluation of HIV-Negative Patients With Low CD4+ T Lymphocyte Counts (NCT00001319) | National Institute of Allergy and Infectious Diseases (NIAID) | 1992-09-01 |
| Viral Load in Blood and Lymph Tissues in People Living With HIV (NCT00001316) | National Institute of Allergy and Infectious Diseases (NIAID) | 1992-08-26 |
| A Registry of Tuberculosis Cases in the CPCRA (NCT00000785) | National Institute of Allergy and Infectious Diseases (NIAID) | 1992-08-01 |
| Treatment of Non-Tuberculous Mycobacterial Infections With Interferon Gamma (NCT00001318) | National Institute of Allergy and Infectious Diseases (NIAID) | 1992-08-01 |
| A Phase IV Study of Recombinant Human Gamma Interferon in Patients With Chronic Granulomatous Diseases of Childhood (NCT00001317) | National Institute of Allergy and Infectious Diseases (NIAID) | 1992-05-01 |
| A Phase I/II Study of the Combination of Azidothymidine and Interleukin-2 (IL-2) in the Treatment of HIV-Infected Patients (NCT00001282) | National Institute of Allergy and Infectious Diseases (NIAID) | 1991-07-01 |
| Phase III Randomized, Double-Blind, Placebo-Controlled Study of Acellular and Whole-Cell Pertussis Vaccines (NCT00004799) | National Institute of Allergy and Infectious Diseases (NIAID) | 1991-04-01 |
| Host Response to Infection and Treatment in Filarial Diseases (NCT00001230) | National Institute of Allergy and Infectious Diseases (NIAID) | 1991-03-15 |
| Itraconazole for the Prevention of Fungal Infections in Chronic Granulomatous Disease (NCT00001280) | National Institute of Allergy and Infectious Diseases (NIAID) | 1991-01-01 |
| Inflammatory Responses in Normal Volunteers and Patients With Abnormal Immune Responses (NCT00001257) | National Institute of Allergy and Infectious Diseases (NIAID) | 1990-04-24 |
| Steroids and Methotrexate to Treat Systemic Vasculitis (NCT00001256) | National Institute of Allergy and Infectious Diseases (NIAID) | 1990-03-01 |
| Immune Regulation in Patients With Common Variable Immunodeficiency and Related Inborn Errors of Immunity (IEI) (NCT00001244) | National Institute of Allergy and Infectious Diseases (NIAID) | 1990-01-15 |
| Study of Patients With Strongyloides Stercoralis Infection (NCT00001245) | National Institute of Allergy and Infectious Diseases (NIAID) | 1989-08-01 |
| Effects of HIV on the Development and Function of Bone Marrow Cells (NCT00001243) | National Institute of Allergy and Infectious Diseases (NIAID) | 1989-02-01 |
| Leprosy Skin Test Antigens Phase 1 (NCT01920750) | National Institute of Allergy and Infectious Diseases (NIAID) | 1989-01-01 |
| Effectiveness of Zidovudine vs. Zidovudine Plus Alpha Interferon vs. Interferon for Treatment of HIV (NCT01125228) | National Institute of Allergy and Infectious Diseases (NIAID) | 1988-10-19 |
| LCI Apheresis to Obtain Plasma or White Blood Cells (NCT00562601) | National Institute of Allergy and Infectious Diseases (NIAID) | 1988-03-28 |
| Natural History of Treated Neurocysticercosis and Long-Term Outcomes (NCT00001205) | National Institute of Allergy and Infectious Diseases (NIAID) | 1985-10-07 |
| Multicenter AIDS Cohort Study (MACS) (NCT00046280) | National Institute of Allergy and Infectious Diseases (NIAID) | 1984-04-01 |
| Apheresis to Obtain Plasma or White Blood Cells for Laboratory Studies (NCT00114647) | National Institute of Allergy and Infectious Diseases (NIAID) | 1984-01-09 |
| Studies of In Vitro B Lymphocyte Responses in Subjects Receiving Tetanus Toxoid Booster Immunization (NCT00001173) | National Institute of Allergy and Infectious Diseases (NIAID) | 1980-06-01 |
| Clinical Investigation of Infections Due to Leishmanial Parasites (NCT00001169) | National Institute of Allergy and Infectious Diseases (NIAID) | 1979-12-01 |
| Diagnosis and Management of Inflammatory and Infectious Diseases (NCT00557726) | National Institute of Allergy and Infectious Diseases (NIAID) | 1978-02-17 |
| Parasitic Infections of the Gastrointestinal Tract (NCT00001162) | National Institute of Allergy and Infectious Diseases (NIAID) | 1977-05-23 |
| Treatment of Wegener's Granulomatosis With Cyclophosphamide (NCT00001155) | National Institute of Allergy and Infectious Diseases (NIAID) | 1976-02-01 |
| Safety and Effectiveness of the Vaccine ALVAC-HIV vCP205 in HIV-Negative Adult Volunteers in Uganda (NCT00007423) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| The Safety of Different Dose Levels of Zidovudine in HIV-Infected Children (NCT00000983) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I Open-Label Study of the Safety, Tolerance, and Pharmacokinetic Interactions of Combination Didanosine and Ribavirin in HIV-Positive Individuals (NCT00000772) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study to Learn More About MAC Disease and the Use of Anti-HIV Drugs in Patients With Advanced HIV Infection (NCT00000895) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I, Placebo-Controlled, Dose-Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Thalidomide in Subjects With HIV-1 Infection (NCT00000812) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Primary Prophylaxis of Cerebral Toxoplasmosis in HIV-Infected Patients (NCT00000643) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| UMD rPA Regimen Trial in Adults (NCT00133484) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Multicenter Study To Determine Foscarnet Dose Response in HIV Infected Patients With PGL and/or Constitutional Disease (NCT00000729) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of the Effectiveness of Different Anti-HIV Treatments in HIV-Positive Individuals Who Have Been on a Protease Inhibitor-Containing Drug Regimen for at Least 16 Weeks (NCT00000914) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Use of a Varicella-Zoster Virus (VZV) Vaccine to Prevent Shingles in HIV-Infected Children Who Have Already Had Chickenpox (NCT00001125) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase III Randomized Trial of Low-Dose Versus Standard-Dose mBACOD Chemotherapy With rGM-CSF for Treatment of AIDS-Associated Non-Hodgkin's Lymphoma (NCT00000658) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Phase I Pharmacokinetic and Tolerance Study of Ribavirin in Human Immunodeficiency Virus (HIV) - Infected Patients (NCT00000733) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| The Safety and Effectiveness of Zidovudine (AZT) in the Treatment of HIV Infection in Patients With AIDS and Advanced ARC (NCT00000999) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Effects of Ribavirin on Zidovudine or Stavudine (NCT00021632) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Comparison of ddI Versus Zidovudine in HIV-Infected Patients (NCT00000979) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I/II Double-Blind Controlled Trial to Determine the Safety and Immunogenicity of HIV-1 MN rgp160 Immuno AG Vaccine Therapy in HIV-Infected Individuals With Greater Than or Equal to 500/mm3 CD4+ T Cells and 200-400/mm3 CD4+ T Cells (NCT00000822) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Ritonavir and Indinavir in Children Failing Other Anti-HIV Treatment (NCT00012519) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I, Multicenter, Randomized Trial to Evaluate the Safety and Immunogenicity of Vaccinia-Derived MN HIV-1 Recombinant Envelope Glycoprotein (rgp160) of Human Immunodeficiency Virus at Two Different Vaccination Schedules (NCT00001043) | National Institute of Allergy and Infectious Diseases (NIAID) | |